Medicamen Biotech

Medicamen Biotech EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medicamen Biotech (MEDICAMEQ.NS) as of Oct 20, 2026 is 123.69 M INR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 201.02 M INR — a change of -38.47% (lower).

EBITDA

123.69 MINR

YoY

-38.47%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medicamen Biotech is 2026 123.69 M INR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medicamen Biotech was 2025 201.02 M INR. It decreases by -38.47% lower compared to the previous year.

The Medicamen Biotech EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
206.70 M INR
Jan 1, 2020
214.12 M INR
Jan 1, 2021
200.16 M INR
Jan 1, 2022
244.77 M INR
Jan 1, 2023
246.13 M INR
Jan 1, 2024
587.78 M INR
Jan 1, 2025
201.02 M INR
Jan 1, 2026
123.69 M INR
The Medicamen Biotech EBITDA history
YEAREBITDAYoY
123.69 MINR-38.47%
201.02 MINR-65.80%
587.78 MINR+138.81%
246.13 MINR+0.56%
244.77 MINR+22.29%
200.16 MINR-6.52%
214.12 MINR+3.59%
206.70 MINR+23.05%
167.98 MINR+103.00%
82.75 MINR+216.84%
26.12 MINR+17.78%
22.18 MINR+23.98%
17.89 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Medicamen Biotech Stock analysis

What does Medicamen Biotech do? Medicamen Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medicamen Biotech stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medicamen Biotech is 123.69 M INR in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medicamen Biotech changed from 201.02 M INR to 123.69 M INR, representing a -38.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Medicamen Biotech since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Medicamen Biotech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Medicamen Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Medicamen Biotech